[ad_1]
The World Health Organization (WHO) has issued new guidelines to improve the treatment of multidrug-resistant tuberculosis. WHO recommends switching to a fully oral regimen for treating people with MDR-TB.
This new treatment is more effective and less likely to cause unwanted side effects. The WHO recommends strengthening treatment with active drug safety surveillance and providing psychological support to help patients complete their treatment.
The recommendations are part of a larger set of actions designed to help countries accelerate the pace of progress in TB control and published before World TB Day. The WHO program is designed to help countries fill gaps in care by ensuring that no one is left behind.
Tuberculosis is the leading killer of infectious diseases in the world, killing 4,500 people a day. The heaviest burden is borne by communities facing socio-economic challenges, those who work and live in high-risk environments, the poorest and marginalized.
The WHO consolidated guidelines on drug-resistant drugs are available at http://bit.ly/TBguideline2019
Source link
